We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds. In this article, we are ...

Despite reporting impressive numbers—122% revenue growth ... Vertex Pharmaceutical Inc. (NASDAQ:VRTX) with a steady revenue stream and supporting its continued investment in research and ...

Vertex Pharmaceuticals (VRTX) closed at $489.43 in the latest trading session, marking a +0.84% move from the prior day. This move outpaced the S&P 500's daily gain of 0.13%. At the same time, the Dow ...

Despite reporting impressive numbers—122% revenue growth ... providing Vertex Pharmaceutical Inc. (NASDAQ:VRTX) with a steady revenue stream and supporting its continued investment in research and ...

The stock of Vertex Pharmaceuticals Incorporated VRTX has ... expansion to younger age groups should drive CF sales growth, the potential launch of Vertex’s fifth CFTR modulator therapy, vanza ...

So our pharmaceutical is effectively a drone ... But that means we have an infrastructure problem. Where to do the research and to conduct the clinical trials and treat patients.

both Vertex Pharmaceuticals Incorporated and Regeneron Pharmaceuticals Inc have a grade of A. For investors who focus solely on a company’s upward growth, further research should be conducted into ...

The stabilizing and dominant financial force throughout 2006 was the deal making among biotech and pharmaceutical ... geared up with ten pivotal research trials; Vertex (Cambridge, MA, USA ...